Liabilities / Assets
54th percentile
Higher debt load relative to assets than 54% of similar nonprofits.
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
54th percentile
Higher debt load relative to assets than 54% of similar nonprofits.
Liabilities / Revenue
56th percentile
Higher debt load relative to revenue than 56% of similar nonprofits.
Net Margin
87th percentile
Higher net margin than 87% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
97th percentile
Faster asset growth than 97% of similar nonprofits.
Revenue Growth
99th percentile
Faster revenue growth than 99% of similar nonprofits.
Assets
Up$88,654
Up $68,136 (+332%) from 2010
Net Assets
Up$88,606
Up $70,806 (+398%) from 2010
Liabilities
Down$48
Down $2,670 (-98%) from 2010
Revenue
Up$205,665
Up $183,486 (+827%) from 2010
Expenses
Up$134,859
Up $108,015 (+402%) from 2010
Net Income
Up$70,806
Up $75,471 (+1618%) from 2010
This 2011 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Fund research and experimentation expenses to find a cure for the deadly genetic disease mucopolysaccharidosis, and assist victims of the disease.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2011 • Form 990Summary only. Only limited summary data is available for this year.